RecruitingNCT02393703

Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

181 participants

Start Date

Mar 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to isolate and analyze exosomes, which are tiny carriers of important proteins and nucleic acids that serve as messenger systems in the blood and tissue. Blood and tissue from patients with pancreatic cancer will be compared with blood and tissue from patients with noncancerous pancreatic disease. Including patients without cancer will allow the investigators to establish "normal" values, which currently do not exist. The investigators will then look to see whether exosome activity has a connection to disease recurrence and outcomes in patients. The results of this study will be the basis for future studies exploring this area.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood samples from patients undergoing pancreatic surgery to better understand how cancer cells communicate with the rest of the body through tiny particles called exosomes, which may help explain why some patients do better than others after surgery. **You may be eligible if...** - You are 18 or older - You are scheduled for surgery to remove all or part of the pancreas, or part of the small intestine, for a suspected or known pancreatic tumor or other pancreatic condition **You may NOT be eligible if...** - Your cancer has spread to other organs or cannot be surgically removed - You received chemotherapy or radiation for this cancer within the last 6 months (for most parts of the study) - Your blood clotting levels are abnormal - You have a known clotting disorder or are on blood thinners - Your tumor shows signs of being invasive on imaging - The surgeon determines that collecting blood samples would put you at risk Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Memorial Sloan Kettering Cancer Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02393703


Related Trials